Alnylam Pharmaceuticals
ALNY
#439
Rank
HK$412.84 B
Marketcap
HK$3,125
Share price
2.43%
Change (1 day)
63.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company